Tumour Ablation Devices Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Tumour Ablation Devices Market: Product Type  (Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, Tissue Spray Probe Ablators)  Application  (Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Renal Cancer, Others)  End User  (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

 

1. Executive Summary+E1:E217
2. Global Tumour Ablation Devices Market Introduction
2.1. Global Tumour Ablation Devices Market – Taxonomy
2.2. Global Tumour Ablation Devices Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End User
3. Global Tumour Ablation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Tumour Ablation Devices Market Dynamic Factors – Impact Analysis
3.6. Global Tumour Ablation Devices Market – Competition Landscape
3.7. Epidemiology
4. Global Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 20228- 202
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Tumour Ablation Devices Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Tissue Contact Probe Ablators
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Epidermal and Subcutaneous Cryoablation Systems
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Tissue Spray Probe Ablators
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Tumour Ablation Devices Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Breast Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Prostate Cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Lung Cancer
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Liver Cancer
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Renal Cancer
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Tumour Ablation Devices Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Hospitals
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Specialty Clinics
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Tumour Ablation Devices Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2022 – 2028
9. North America Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tissue Contact Probe Ablators
9.1.2. Epidermal and Subcutaneous Cryoablation Systems
9.1.3. Tissue Spray Probe Ablators
9.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Breast Cancer
9.2.2. Prostate Cancer
9.2.3. Lung Cancer
9.2.4. Liver Cancer
9.2.5. Renal Cancer
9.2.6. Others
9.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Ambulatory Surgical Centers
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
9.6. North America Tumour Ablation Devices Market Dynamics – Trends
10. Europe Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tissue Contact Probe Ablators
10.1.2. Epidermal and Subcutaneous Cryoablation Systems
10.1.3. Tissue Spray Probe Ablators
10.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Breast Cancer
10.2.2. Prostate Cancer
10.2.3. Lung Cancer
10.2.4. Liver Cancer
10.2.5. Renal Cancer
10.2.6. Others
10.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Ambulatory Surgical Centers
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
10.6. Europe Tumour Ablation Devices Market Dynamics – Trends
11. Asia-Pacific Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tissue Contact Probe Ablators
11.1.2. Epidermal and Subcutaneous Cryoablation Systems
11.1.3. Tissue Spray Probe Ablators
11.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Breast Cancer
11.2.2. Prostate Cancer
11.2.3. Lung Cancer
11.2.4. Liver Cancer
11.2.5. Renal Cancer
11.2.6. Others
11.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Ambulatory Surgical Centers
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
11.6. Asia-Pacific Tumour Ablation Devices Market Dynamics – Trends
12. Latin America Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Tissue Contact Probe Ablators
12.1.2. Epidermal and Subcutaneous Cryoablation Systems
12.1.3. Tissue Spray Probe Ablators
12.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Breast Cancer
12.2.2. Prostate Cancer
12.2.3. Lung Cancer
12.2.4. Liver Cancer
12.2.5. Renal Cancer
12.2.6. Others
12.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Ambulatory Surgical Centers
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
12.6. Latin America Tumour Ablation Devices Market Dynamics – Trends
13. Middle East and Africa Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Tissue Contact Probe Ablators
13.1.2. Epidermal and Subcutaneous Cryoablation Systems
13.1.3. Tissue Spray Probe Ablators
13.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Breast Cancer
13.2.2. Prostate Cancer
13.2.3. Lung Cancer
13.2.4. Liver Cancer
13.2.5. Renal Cancer
13.2.6. Others
13.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Ambulatory Surgical Centers
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
13.6. MEA Tumour Ablation Devices Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Boston Scientific Corporation
14.2.2. Cooper Surgical
14.2.3. Sanarus Technologies
14.2.4. Atricure, Inc.
14.2.5. IceCure Medical
14.2.6. CPSI Biotech
14.2.7. HealthTronics, Inc.
14.2.8. RA Distribution
14.2.9. Brymill Cryogenic Systems
14.2.10. Erbe Elektromedizin, GmbH
15. Research Methodology
16. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Boston Scientific Corporation
  • Cooper Surgical
  • Sanarus Technologies
  • Atricure, Inc.
  • IceCure Medical
  • CPSI Biotech
  • HealthTronics, Inc.
  • RA Distribution
  • Brymill Cryogenic Systems
  • Erbe Elektromedizin, GmbH

Description

 

1. Executive Summary+E1:E217
2. Global Tumour Ablation Devices Market Introduction
2.1. Global Tumour Ablation Devices Market – Taxonomy
2.2. Global Tumour Ablation Devices Market –Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End User
3. Global Tumour Ablation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Tumour Ablation Devices Market Dynamic Factors – Impact Analysis
3.6. Global Tumour Ablation Devices Market – Competition Landscape
3.7. Epidemiology
4. Global Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 20228- 202
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Tumour Ablation Devices Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Tissue Contact Probe Ablators
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Epidermal and Subcutaneous Cryoablation Systems
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Tissue Spray Probe Ablators
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Tumour Ablation Devices Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Breast Cancer
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Prostate Cancer
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Lung Cancer
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Liver Cancer
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Renal Cancer
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Tumour Ablation Devices Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Hospitals
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Specialty Clinics
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Tumour Ablation Devices Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2022 – 2028
9. North America Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Tissue Contact Probe Ablators
9.1.2. Epidermal and Subcutaneous Cryoablation Systems
9.1.3. Tissue Spray Probe Ablators
9.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Breast Cancer
9.2.2. Prostate Cancer
9.2.3. Lung Cancer
9.2.4. Liver Cancer
9.2.5. Renal Cancer
9.2.6. Others
9.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Ambulatory Surgical Centers
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
9.6. North America Tumour Ablation Devices Market Dynamics – Trends
10. Europe Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Tissue Contact Probe Ablators
10.1.2. Epidermal and Subcutaneous Cryoablation Systems
10.1.3. Tissue Spray Probe Ablators
10.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Breast Cancer
10.2.2. Prostate Cancer
10.2.3. Lung Cancer
10.2.4. Liver Cancer
10.2.5. Renal Cancer
10.2.6. Others
10.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Ambulatory Surgical Centers
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
10.6. Europe Tumour Ablation Devices Market Dynamics – Trends
11. Asia-Pacific Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Tissue Contact Probe Ablators
11.1.2. Epidermal and Subcutaneous Cryoablation Systems
11.1.3. Tissue Spray Probe Ablators
11.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Breast Cancer
11.2.2. Prostate Cancer
11.2.3. Lung Cancer
11.2.4. Liver Cancer
11.2.5. Renal Cancer
11.2.6. Others
11.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Ambulatory Surgical Centers
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
11.6. Asia-Pacific Tumour Ablation Devices Market Dynamics – Trends
12. Latin America Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Tissue Contact Probe Ablators
12.1.2. Epidermal and Subcutaneous Cryoablation Systems
12.1.3. Tissue Spray Probe Ablators
12.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Breast Cancer
12.2.2. Prostate Cancer
12.2.3. Lung Cancer
12.2.4. Liver Cancer
12.2.5. Renal Cancer
12.2.6. Others
12.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Ambulatory Surgical Centers
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
12.6. Latin America Tumour Ablation Devices Market Dynamics – Trends
13. Middle East and Africa Tumour Ablation Devices Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. By Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Tissue Contact Probe Ablators
13.1.2. Epidermal and Subcutaneous Cryoablation Systems
13.1.3. Tissue Spray Probe Ablators
13.2. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Breast Cancer
13.2.2. Prostate Cancer
13.2.3. Lung Cancer
13.2.4. Liver Cancer
13.2.5. Renal Cancer
13.2.6. Others
13.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Ambulatory Surgical Centers
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Tumour Ablation Devices Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2022 – 2028
13.6. MEA Tumour Ablation Devices Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Boston Scientific Corporation
14.2.2. Cooper Surgical
14.2.3. Sanarus Technologies
14.2.4. Atricure, Inc.
14.2.5. IceCure Medical
14.2.6. CPSI Biotech
14.2.7. HealthTronics, Inc.
14.2.8. RA Distribution
14.2.9. Brymill Cryogenic Systems
14.2.10. Erbe Elektromedizin, GmbH
15. Research Methodology
16. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX